Literature DB >> 1318140

Abortive human cytomegalovirus infection in patients after allogeneic bone marrow transplantation.

G C de Gast1, G J Boland, A M Vlieger, R A de Weger, L F Verdonck, F E Zwaan, N M Jiwa.   

Abstract

Infection with human cytomegalovirus (HCMV) after allogeneic bone marrow transplantation (BMT) was studied in 12 HCMV seronegative recipients of marrow from seropositive donors by weekly monitoring of cultures, expression of HCMV antigenemia (pp65) in granulocytes, polymerase chain reaction (PCR) on HCMV-DNA in granulocytes and IgM and IgG anti-HCMV antibodies. Eight patients remained negative in all tests as did 33 HCMV seronegative recipients of marrow from seronegative donors. In four patients, a transient expression of HCMV antigen pp65 in granulocytes from peripheral blood, together with a positive PCR on HCMV-DNA from the same samples were found without positive cultures, seroconversion or expression of other HCMV antigens in granulocytes. The data indicate the presence of an abortive HCMV infection in these four patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318140

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

1.  Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipients.

Authors:  Steven A Pergam; Hu Xie; Ravinder Sandhu; Margaret Pollack; Jeremy Smith; Terry Stevens-Ayers; Valeria Ilieva; Louise E Kimball; Meei-Li Huang; Tracy S Hayes; Lawrence Corey; Michael J Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2012-03-03       Impact factor: 5.742

2.  Monitoring of leukocyte cytomegalovirus DNA in bone marrow transplant recipients by nested PCR.

Authors:  K Y Yuen; S K Lo; E K Chiu; S S Wong; Y L Lau; R Liang; T K Chan; M H Ng
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

Review 3.  Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants.

Authors:  Ellen Meijer; Greet J Boland; Leo F Verdonck
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

Review 4.  Cytomegalovirus pneumonia in hematopoietic stem cell recipients.

Authors:  Giovanna Travi; Steven A Pergam
Journal:  J Intensive Care Med       Date:  2013-02-06       Impact factor: 3.510

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.